Effect of esmolol on oxidant status and antioxidant activity in acute myocardial infarction

Journal of Association of Physicians of India

Volumn 51, Issue JUL, 2003, Pages 677-680

  Daga, M K ^a   Chaudhary, Madhuchanda ^a   Sharma, Bhavneesh ^a   Bhattacharjee, Jayshree ^a   Ghambhir, D S ^a   Arora, N ^a   Sudha, R ^a  

^a G B PANT HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ESMOLOL; FREE RADICAL; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; OXIDIZING AGENT; PROPANOLAMINE DERIVATIVE;

ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEART INFARCTION; HUMAN; MALE; MIDDLE AGED; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANTIOXIDANTS; DOUBLE-BLIND METHOD; FEMALE; FREE RADICALS; GLUTATHIONE PEROXIDASE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; OXIDANTS; PROPANOLAMINES; PROSPECTIVE STUDIES;

EID: 2842520405     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Backer JE, Fleix CC, Olinger GN, et al. Myocardial ischemia and reperfusion - direct evidence for free radical generation of electron spin resonance spectroscopy. Proc Natl Acad Sci 1988;85:2786-89.
2. Bolli R, Jeroudi MO, Patel BS, et al. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at time of reperfusion. Circ Res 1989;66:607-22.
3. Askenazi J, Hoft JV, Turtapaty P, et al. The effects of esmolol on cardiac hemodynamic function. Clin Res 1985;33:167A.
4. Iskandrin AS, Bemis CE, Hakki AH, et al. Effects of esmolol on patients with left ventricular dysfunction. J Am Coll Cardiol 1986;8:225-31.
5. Takayama H, Okuma M, Uchino H. A simple method for estimation of lipooxygenase and cyclooxygenase pathways in human platelets - the use of thiobarbituric acid reaction. Thromb Haemost 1980;44:111-14.
6. Vartanian CS, Gurevich SM. Determination of superoxide dismutase activity in animal tissues by the means of nitroblue tetrazolium. Vopr Med Khim 1982;28:23-26.
7. Dever S, Vegas C, Imbert-Bismulf, et al. Adaptation of the measurement of plasma and erythrocyte glutathione peroxidase activity on Hitachi 911. Ann Biol Clin (Paris) 1996;54:199-202.
8. Yagi K. Lipid peroxide and human disease. Chem Phys Lipids 1987;45:37-51.
9. Kirshenbaum JM, Klaner RA, Antman EM, et al. Use of an ultra-short acting beta-blocker in patients with acute myocardial ischemia. Circulation 1985;72:873-80.
10. Shalaev SV, Bukhvalov V, Petrik ES, Shabalkov EA. The use of Esmolol in patients with acute myocardial infarction. Kardiologia 2002; 42: 4-7.
11. Manning AS, Hearse DJ. Reperfusion induced arrhythmias: mechanism and prevention. J Mol Cell Cardiol 1984;76:497-518.
12. Bhagat BD, Rao PS, Dhall NS. The role of catecholamines in the genesis of arrhythmias. Adv Myocardiol 1980;2:117-21.
13. Loeper J, Gay J, Klein M, et al. Evolution of oxidative stress indicators in the course of myocardial ischemia. Free Radic Res Commun 1991;12-13:675-80.
14. Kharb S, Singh GP. Effect of smoking on lipid profile, lipid peroxidation and antioxidant status in normal subjects and in patients during and after myocardial infarction. Clin Chim Acta 2000;302:213-219.
15. Currello S, Cernic C, Brigolic R, et al. Changes of the cardiac glutathione status after ischemia and reperfusion. Experiontia 1985;41:42-43.
16. Ferrari R, Ceconi C, Curello S, et al. Oxygen mediated myocardial damage during ischemia and reperfusion - role of the cellular defenses against oxygen toxicity. J Mol Coll Cardiol 1985;17:937-45.
17. Muzakova V, Kandar R, Vojtisek P, Skalicky J, Cervinkova Z. Selective antioxidant enzymes during ischemia/reperfusion in myocardial infarction. Physiol Res 2000;49:315-22.
18. Muzakova V, Kandar R, Vojtisek P, Skalicky J, Vankova R, Cegan A, Cervinkova Z. Antioxidant vitamin levels and glutathione peroxidase activity during ischemia/reperfusion in myocardial infarction. Physiol Res 2001;50:389-96.
19. Gessler HJ. Reduction of myocardial reperfusion injury by high dose beta-blockade with esmolol. Thorac Cardiovasc Surg 2002;50:367-72.
20. Roth E, Torok B. Effect of the ultra-short acting beta-blocker Brevibloc on free radical mediated injuries during the early reperfusion state. Basic Res Cardiol 1991;86:422-33.